Seroquel, Quetiapine Wire
Comprehensive News Feed for Seroquel, Quetiapine (generic).
Results 1 - 20 of 57 in Seroquel, Quetiapine (generic)
-
Boomer Consumer: Should you take Seroquel XR to treat depression?
More than half of the people who take antidepressants continue to suffer from depression. Comment?
-
FDA Approves Seroquel XR For Add-On Treatment of Major Depressive Disorder
WILMINGTON, Del., Dec. 4 /PRNewswire-FirstCall/ -- AstraZeneca today announced that the US Food and Drug Administration has approved once-daily Seroquel XR Extended Release Tablets as adjunctive treatment to antidepressants in adults with Major Depressive Disorder . Comment?
-
Analyst Report ) once again! The company received US Food and Drug Administration approval for Seroquel XR as an add-on treatment to antidepressants in adults with Major Depressive Disorder . Comment?
-
FDA Approves Seroquel XR For Add-On Treatment Of Major Depressive Disorder
AstraZeneca has announced that the FDA has approved once-daily SEROQUEL XR Extended Release Tablets as adjunctive treatment to antidepressants in adults with Major Depressive Disorder . Comment?
-
FDA approves Seroquel XR as add-on treatment for major depressive disorder
WILMINGTON,A Del. The Food and Drug Administration has approved an AstraZeneca drug as an add-on treatment to antidepressants in adults with major depressive disorder. 1 comment
-
Seroquel Gains FDA Approvals for Add-on Depression Treatment, Pediatric Schizophrenia
The U.S. Food and Drug Administration announced this past week that two types of Seroquel-brand atypical antipsychotic medications have been approved for two different mental health treatments - for use as an add-on treatment for depression , and for pediatric schizophrenia and bipolar mania . Comment?
-
Us Fda Approves Seroquel XR(R) For Add-On Treatment Of Major Depressive Disorder
Main Category: Depression Also Included In: Regulatory Affairs / Drug Approvals ; Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 05 Dec 2009 - 1:00 PST AstraZeneca announced that the US Food and Drug Administration has approved once-daily SEROQUEL XR Extended Release Tablets as adjunctive treatment to ... Comment?
-
Why AstraZeneca's $1B Antidepressant Bet Faces Big Risks
AstraZeneca is doubling down on major depression with a $1.2 billion deal for TC-5214 , a molecule in development at Targacept . Comment?
-
Fda approves AstraZeneca's Seroquel XR as add-on treatment of MDD
SEROQUEL XR is the only medication in its class approved by the FDA to treat both major depressive disorder as adjunctive therapy and acute depressive episodes associated with bipolar disorder as monotherapy. Comment?
-
Us Fda Approves AstraZeneca PLC's Seroquel XR(R) For Add-On Treatment of Major Depressive Disorder
WILMINGTON, Del., Dec. 4 /PRNewswire-FirstCall/ -- AstraZeneca today announced that the US Food and Drug Administration has approved once-daily SEROQUEL XRA Extended Release Tablets as adjunctive treatment to antidepressants in adults with Major Depressive Disorder . Comment?
-
Fda approves once-daily Seroquel XR Extended Release Tablets
AstraZeneca today announced that the US Food and Drug Administration has approved once-daily SEROQUEL XRA Extended Release Tablets as adjunctive treatment to antidepressants in adults with Major Depressive Disorder . Comment?
-
Moody Market Clips Targacept Despite Major Depression Deal
The deal for Phase II adjunctive depression candidate TC-5214 with Targacept Inc. Comment?
-
New Safety Concern Related To Antipsychotic Treatment
Overall, antipsychotic medications are reasonably effective, and fairly well tolerated treatments for mood and psychotic disorders. Comment?
-
Decision Resources projects decrease in antipsychotic drug market
WALTHAM,A Mass. The market for drugs used to treat schizophrenia will decrease by more than $1 billion over the next four years due to generic competition, according to a new report. Comment?
-
Wikipedia, AstraZeneca and Seroquel A Experimental Chimp
After all, Wikipedia has become a lot of people's source of choice, at least as a starting point for further research. Comment?
-
Children 'highly vulnerable' to antipsychotic drugs
Up to a third of children and adolescents who took common antipsychotic drugs for the first time became overweight or obese in as little as 11 weeks, raising their risk for diabetes and heart disease, U.S. researchers said Tuesday. Comment?
-
Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the...
Tel: +615 327 7049; Fax: +615 327 7093; E-mail: Herbert.meltzer@vanderbilt.edu Received 24 May 2009; Revised 15 September 2009; Accepted 16 September 2009; Published online 11 November 2009. Comment?
-
Is your doctor's continuing ed funded by pharma?
Raise your hand if you've breathed a sigh of relief seeing your doctor had a CME certificate next to the medical school diploma on the wall. Comment?
-
Addiction Inbox: The Black Market for Seroquel
Speed freaks, coke heads, and antipsychotics. Last week, writing on the Daily Beast web site, reporter Jeff Deeney profiled a startling underground market for the antipsychotic medication Seroquel . Comment?
-
OpEdNews - Article: Aren't You Glad Your Doctor Completed Pharma's CMEs?
By Martha Rosenberg Page 1 of 2 page opednews.com Raise your hand if you've breathed a sign of relief seeing your doctor had a CME certificate next to the medical school diploma on the wall. Comment?
Seroquel, Quetiapine Forum
Most Popular
- WE MUST START PROFILING MUSLIMS AT AIRPORTS - 539 comments
- Ted Nugent: Obama a Communist, Should Be Jailed - 360 comments
- Costly Benefits for Same-Sex Couples - 287 comments
- Amnesty push coming again a " be ready - 146 comments
- President Barack Obama_20091124100750_JPG - 110 comments
- Three shot at Baxley night club - 73 comments
- GOP candidate runs ad citing 'rumors' opponent is gay - 55 comments
- Al-Qaida group says it was behind jetliner attack - 86 comments
- The History of Slavery in America - 70 comments
- Bradley J. Hobson, 51 - 54 comments
|
Reach local customers. Engage a specific demographic. Maximize business-to-business opportunities. Topix can deliver your message.
|
Copyright ©2009 Topix LLC
